Amarin Corp Plcuk (AMRN) Depreciation & Amortization (CF) (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Depreciation & Amortization (CF) of $1000.0 for Q1 2026, little changed YoY from $1000.0 in Q1 2025, and little changed sequentially from $1000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $1000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $4000.0 (down 93.94% YoY), while the FY2025 annual figure was $4000.0, down 95.92% from the prior year.
  • Depreciation & Amortization (CF) was little changed at $1000.0 in Q1 2026, from $1000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for AMRN reached as high as $144000.0 in Q1 2022 and fell as low as $1000.0 in Q1 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $32000.0 (2024), against an average of $47882.4.
  • Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) gained 3.23% — and 2025, when it sank 96.97%.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $125000.0 in 2022, then plunged by 73.6% to $33000.0 in 2023, then plunged by 75.76% to $8000.0 in 2024, then plunged by 87.5% to $1000.0 in 2025, then changed by 0.0% to $1000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1000.0, $1000.0, and $1000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 509.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.00 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 188.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 1.37 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 581.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.12 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 93.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 1.61 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 1,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
Mar 31, 2026 1,000.00
Dec 31, 2025 1,000.00
Dec 31, 2025 1,000.00
Sep 30, 2025 1,000.00
Sep 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 8,000.00
Dec 31, 2024 8,000.00
Sep 30, 2024 25,000.00
Sep 30, 2024 25,000.00
Jun 30, 2024 32,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 33,000.00
Mar 31, 2024 33,000.00
Dec 31, 2023 33,000.00
Dec 31, 2023 33,000.00